Physician profile
Harry Cotler
NPI 1730176249
$841.60
in general payments reported to CMS, 2019-2025
21 companies · $24.00 in 2025
The $24.00 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $40.78 · 2021: $198 · 2022: $81.33 · 2023: $183 · 2024: $182 · 2025: $24.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $138.51 | 2019-2023 | Krystexxa |
| Averitas Pharma INC. | $119.68 | 2024 | Qutenza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $100.00 | 2021 | |
| Abbvie INC. | $63.57 | 2021-2023 | Dalvance |
| Kerecis Limited | $53.09 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $50.27 | 2020-2023 | Grafix Pl |
| Grt US Holding, INC. | $35.92 | 2022 | |
| Nevro Corp. | $31.86 | 2022-2024 | Senza |
| Organogenesis INC. | $31.35 | 2019-2023 | Puraply |
| Amgen INC. | $27.40 | 2024 | Krystexxa |
| Depuy Synthes Sales INC. | $24.51 | 2021 | |
| Globus Medical, INC. | $24.00 | 2025 | Senza |
| Heron Therapeutics, INC. | $21.71 | 2021 | |
| Melinta Therapeutics, LLC | $20.45 | 2019 | |
| Medtronic, INC. | $17.48 | 2023 | Intellis Adaptivestim |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Triad Life Sciences INC. | $16.40 | 2022 | |
| Ermi LLC | $15.31 | 2023 | |
| Cashflow Solutions, LLC | $13.19 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Musculoskeletal Transplant Foundation INC. | $13.16 | 2019 | |
| Assertio Therapeutics, INC. | $12.63 | 2020 | |
| Zimmer Biomet Holdings, INC. | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Cotler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.